Who Is Elizabeth Ries
Elizabeth Ries is an American actress best known for playing Cruella de Vil in the Netflix series Wednesday. In the show, her character uses Ozempic, a prescription medication originally approved to manage type 2 diabetes and, in higher doses, to support weight management. Outside of acting, public reports indicate Ries has spoken about using Ozempic for personal weight loss. This article outlines verified details about her role, the medical context of Ozempic, and clarifies the relationship between the actress, the medication, and public discussion.
Elizabeth Ries Role in Wednesday
In the Addams Family spin-off series Wednesday, Elizabeth Ries appears as a recurring character linked to the school setting. Her portrayal contributes to the show’s ensemble cast and storylines. While the series includes scenes referencing medical treatments for narrative purposes, the health choices of actors remain personal. Understanding the distinction between character context and an actor’s private decisions helps avoid unfounded assumptions.
Ozempic in the Show’s Storylines
The series makes narrative references to Ozempic, aligning with real-world uses for blood sugar control and weight management. These mentions serve storytelling rather than direct commentary on any individual’s health. Viewers are encouraged to separate dramatized elements from real medical practice, especially when considering treatment options.
What Ozempic Is and How It Works
Ozempic is a once-weekly injection containing semaglutide, approved by the FDA to improve glycemic control in adults with type 2 diabetes. It mimics a hormone that regulates blood sugar and slows gastric emptying. At higher doses under the brand name Wegovy, semaglutide is also authorized for chronic weight management in people with obesity or weight-related conditions. Common side effects include nausea, vomiting, diarrhea, and abdominal pain, with rare risks such as thyroid tumors observed in animal studies.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Active ingredient | Semaglutide | FDA label |
| Primary uses | Type 2 diabetes management, chronic weight management (Wegovy) | FDA approvals |
| Administration | Once-weekly subcutaneous injection | Prescribing information |
| Common side effects | Nausea, vomiting, diarrhea, abdominal pain | Clinical trial data |
| Serious warnings | Thyroid C-cell tumors in animal studies; not recommended for personal or family history of medullary thyroid carcinoma or MEN2 | FDA boxed warning |
Ozempic Use in the General Population
Ozempic and Wegovy are prescribed to help lower blood sugar and promote weight loss when used alongside diet and exercise. They are not approved for cosmetic weight loss in people without diabetes or obesity. Use requires medical supervision due to potential side effects, cost, and the need for ongoing monitoring. Misuse or off-label pursuit without clinical oversight can lead to health complications.
Public Discussion and Responsible Reporting
When public figures mention medications like Ozempic, conversations often shift to broader topics such as body image, access, and safety. Responsible reporting emphasizes evidence-based facts, distinguishes between treatment and appearance, and avoids implying that medical choices define a person’s worth. Accurate framing supports informed public understanding and reduces stigma.
Key Facts at a Glance
- Elizabeth Ries is known for playing Cruella in the Netflix series Wednesday.
- Ozempic is a brand name for semaglutide used to manage type 2 diabetes; Wegovy is the higher-dose semaglutide used for weight management.
- Any use of Ozempic for weight loss should be medically supervised and is intended for eligible patients with obesity or related conditions.
- Reported side effects can include gastrointestinal symptoms and rare risks noted in animal studies; people with certain medical histories should not use it.
- Actors’ personal health decisions are private; storylines may reference treatments without reflecting an actor’s actual use or choices.
Clarifying Rumors and Context
Speculation about specific individuals’ use of medications based on appearance or roles can be misleading. Health decisions are personal and influenced by many factors not visible publicly. Reliable sources such as FDA labels, healthcare providers, and official statements are essential when discussing treatments. Maintaining factual accuracy protects individuals and supports thoughtful public discourse.
Conclusion
Elizabeth Ries is recognized for her role in Wednesday, where storylines may include references to medications like Ozempic. Ozempic and Wegovy are approved treatments with specific medical uses and risks. Public conversations benefit from clarity, verified facts, and respect for personal privacy. This overview combines verified information about the actress, the medication, and responsible context to support informed and balanced understanding.